Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrase polymorphism and HIV-1 group O diversity.
Leoz M, Depatureaux A, Vessière A, Roquebert B, Damond F, Rousset D, Roques P, Simon F, Plantier JC; RES-O group. Leoz M, et al. Among authors: depatureaux a. AIDS. 2008 Jun 19;22(10):1239-43. doi: 10.1097/QAD.0b013e3283021c30. AIDS. 2008. PMID: 18525277 No abstract available.
First report of transmission of a highly resistant strain of HIV-1 group O.
Unal G, Mourez T, Leoz M, Alessandri-Gradt E, Le Guillou-Guillemette H, Chennebault JM, Depatureaux A, Meyer L, Plantier JC; RES-O Surveillance Network. Unal G, et al. Among authors: depatureaux a. AIDS. 2016 Oct 23;30(16):2565-2568. doi: 10.1097/QAD.0000000000001253. AIDS. 2016. PMID: 27753681 No abstract available.
[Specific diagnosis and follow-up of HIV-1 group O infection: RES-O data].
Depatureaux A, Leoz M, De Oliveira F, Gueudin M, Damond F, Descamps D, Brun-Vézinet F, Lemée V, Simon F, Barin F, Plantier JC. Depatureaux A, et al. Med Mal Infect. 2010 Dec;40(12):669-76. doi: 10.1016/j.medmal.2010.04.011. Epub 2010 Jun 19. Med Mal Infect. 2010. PMID: 20646884 French.
Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun.
Vessière A, Rousset D, Kfutwah A, Leoz M, Depatureaux A, Simon F, Plantier JC. Vessière A, et al. Among authors: depatureaux a. J Acquir Immune Defic Syndr. 2010 Jan;53(1):107-10. doi: 10.1097/QAI.0b013e3181b97ec1. J Acquir Immune Defic Syndr. 2010. PMID: 19770803
Raltegravir-based regimens are effective in HIV-1 group O-infected patients.
Depatureaux A, Leoz M, Le Moal G, Pathé JP, Pavie J, Batisse D, Daneluzzi V, Genet P, Gerard L, Lascaux-Cametz AS, Lambolez T, Chennebault JM, Plantier JC. Depatureaux A, et al. J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):e1-3. doi: 10.1097/QAI.0b013e31826327c4. J Acquir Immune Defic Syndr. 2012. PMID: 22918125 No abstract available.
Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide.
Depatureaux A, Charpentier C, Collin G, Leoz M, Descamps D, Vessière A, Damond F, Rousset D, Brun-Vézinet F, Plantier JC. Depatureaux A, et al. Antimicrob Agents Chemother. 2010 Sep;54(9):4016-9. doi: 10.1128/AAC.00100-10. Epub 2010 Jun 14. Antimicrob Agents Chemother. 2010. PMID: 20547806 Free PMC article.
HIV-1 Group O Resistance Against Integrase Inhibitors.
Depatureaux A, Mesplède T, Quashie P, Oliveira M, Moisi D, Plantier JC, Brenner B, Wainberg MA. Depatureaux A, et al. J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):9-15. doi: 10.1097/QAI.0000000000000698. J Acquir Immune Defic Syndr. 2015. PMID: 26017662
19 results